-
1
-
-
0242390079
-
Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
-
Collaborative Group on Hormonal Factors in Breast Cancer
-
Collaborative Group on Hormonal Factors in Breast Cancer 1996 Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies Lancet 347 1713 1727
-
(1996)
Lancet
, vol.347
, pp. 1713-1727
-
-
-
2
-
-
0037434427
-
Hormonal content and potency of oral contraceptives and breast cancer risk among young women
-
MD Althuis DR Brogan RJ Coates et al. 2003 Hormonal content and potency of oral contraceptives and breast cancer risk among young women Br J Cancer 88 50 57
-
(2003)
Br J Cancer
, vol.88
, pp. 50-57
-
-
Althuis, M.D.1
Brogan, D.R.2
Coates, R.J.3
-
5
-
-
0031861731
-
Oral contraceptives and breast cancer in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
-
WC Chie CY Li CS Huang KJ Chang ML Yen RS Lin 1998 Oral contraceptives and breast cancer in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives Int J Cancer 77 219 223
-
(1998)
Int J Cancer
, vol.77
, pp. 219-223
-
-
Chie, W.C.1
Li, C.Y.2
Huang, C.S.3
Chang, K.J.4
Yen, M.L.5
Lin, R.S.6
-
8
-
-
0042018741
-
Breast cancer and hormone-replacement therapy in the Million Women Study
-
Million Women Study Collaborators
-
Million Women Study Collaborators 2003 Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 419 427
-
(2003)
Lancet
, vol.362
, pp. 419-427
-
-
-
9
-
-
0037125379
-
Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial
-
Writing Group for the Women's Health Initiative Investigators
-
Writing Group for the Women's Health Initiative Investigators 2002 Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321 333
-
(2002)
JAMA
, vol.288
, pp. 321-333
-
-
-
10
-
-
0030843969
-
Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
-
Collaborative Group on Hormonal Factors in Breast Cancer
-
Collaborative Group on Hormonal Factors in Breast Cancer 1997 Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 350 1047 1059
-
(1997)
Lancet
, vol.350
, pp. 1047-1059
-
-
-
11
-
-
4544241856
-
Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study
-
K Bakken E Alsaker AE Eggen E Lund 2004 Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study Int J Cancer 112 130 134
-
(2004)
Int J Cancer
, vol.112
, pp. 130-134
-
-
Bakken, K.1
Alsaker, E.2
Eggen, A.E.3
Lund, E.4
-
12
-
-
14044266896
-
Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort
-
(in press).
-
Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F (2004) Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer (in press).
-
(2004)
Int J Cancer
-
-
Fournier, A.1
Berrino, F.2
Riboli, E.3
Avenel, V.4
Clavel-Chapelon, F.5
-
13
-
-
9144262306
-
Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women
-
SA Norman JA Berlin AL Weber 2003 Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women Cancer Causes Control 14 933 943
-
(2003)
Cancer Causes Control
, vol.14
, pp. 933-943
-
-
Norman, S.A.1
Berlin, J.A.2
Weber, A.L.3
Etal4
-
14
-
-
0036467660
-
Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?
-
G Ursin CC Tseng A Paganini-Hill 2002 Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clin Oncol 20 699 706
-
(2002)
J Clin Oncol
, vol.20
, pp. 699-706
-
-
Ursin, G.1
Tseng, C.C.2
Paganini-Hill, A.3
Etal4
-
15
-
-
0031670933
-
Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy
-
LA Brinton DR Brogan RJ Coates CA Swanson N Potischman JL Stanford 1998 Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy Menopause 5 145 151
-
(1998)
Menopause
, vol.5
, pp. 145-151
-
-
Brinton, L.A.1
Brogan, D.R.2
Coates, R.J.3
Swanson, C.A.4
Potischman, N.5
Stanford, J.L.6
-
16
-
-
0003185814
-
Breast cancer and hormonal contraceptives: Further results
-
Collaborative Group on Hormonal Factors in Breast Cancer. Suppl.3
-
Collaborative Group on Hormonal Factors in Breast Cancer 1996 Breast cancer and hormonal contraceptives: Further results Contraception 54 Suppl.3 1S 106S
-
(1996)
Contraception
, vol.54
-
-
-
17
-
-
0029096140
-
Exogenous hormone use and the risk of postmenopausal breast cancer: Results from the Netherlands Cohort Study
-
AG Schuurman A van den Brandt RA Goldbohm 1995 Exogenous hormone use and the risk of postmenopausal breast cancer: results from the Netherlands Cohort Study Cancer Causes Control 6 416 424
-
(1995)
Cancer Causes Control
, vol.6
, pp. 416-424
-
-
Schuurman, A.G.1
Van Den Brandt, A.2
Goldbohm, R.A.3
-
18
-
-
0029060066
-
Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women
-
JL Stanford NS Weiss LF Voigt JR Daling LA Hable MA Rossing 1995 Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women JAMA 274 137 142
-
(1995)
JAMA
, vol.274
, pp. 137-142
-
-
Stanford, J.L.1
Weiss, N.S.2
Voigt, L.F.3
Daling, J.R.4
Hable, L.A.5
Rossing, M.A.6
-
19
-
-
0035945656
-
Estrogen and the risk of breast cancer
-
M Clemons P Goss 2001 Estrogen and the risk of breast cancer N Engl J Med 344 276 285
-
(2001)
N Engl J Med
, vol.344
, pp. 276-285
-
-
Clemons, M.1
Goss, P.2
-
21
-
-
0026732124
-
Nutrition and cancer: Background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC)
-
E Riboli 1992 Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC) Ann Oncol 3 783 791
-
(1992)
Ann Oncol
, vol.3
, pp. 783-791
-
-
Riboli, E.1
-
22
-
-
0028087289
-
Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates
-
DG Altman BL De Stavola 1994 Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates Stat Med 13 301 341
-
(1994)
Stat Med
, vol.13
, pp. 301-341
-
-
Altman, D.G.1
De Stavola, B.L.2
-
23
-
-
11344283814
-
Choice of time-scale in Cox's model analysis of epidemiologic cohort data: A simulation study
-
CMA Thiébaut J Bénichou 2004 Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study Stat Med 23 3803 3820
-
(2004)
Stat Med
, vol.23
, pp. 3803-3820
-
-
Thiébaut, C.M.A.1
Bénichou, J.2
-
24
-
-
0034716353
-
Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
-
C Schairer J Lubin R Troisi S Sturgeon L Brinton R Hoover 2000 Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk JAMA 283 485 491
-
(2000)
JAMA
, vol.283
, pp. 485-491
-
-
Schairer, C.1
Lubin, J.2
Troisi, R.3
Sturgeon, S.4
Brinton, L.5
Hoover, R.6
-
25
-
-
0000641436
-
Applications of stratified analysis methods
-
Lippincott-Raven Philadelphia
-
S Greenland 1998 Applications of stratified analysis methods KJ Rothman S Greenland Modern Epidemiology 2 Lippincott-Raven Philadelphia 297 300
-
(1998)
Modern Epidemiology 2
, pp. 297-300
-
-
Greenland, S.1
Rothman, K.J.2
Greenland, S.3
-
26
-
-
0027396975
-
Age-specific differences in the relationship between oral contraceptive use and breast cancer
-
suppl
-
PA Wingo NC Lee HW Ory V Beral HB Peterson P Rhodes 1993 Age-specific differences in the relationship between oral contraceptive use and breast cancer Cancer 71 suppl 1506 1517
-
(1993)
Cancer
, vol.71
, pp. 1506-1517
-
-
Wingo, P.A.1
Lee, N.C.2
Ory, H.W.3
Beral, V.4
Peterson, H.B.5
Rhodes, P.6
-
28
-
-
0038795406
-
Breast cancer and specific types of oral contraceptives: A large Norwegian cohort study
-
V Dumeaux E Alsaker E Lund 2003 Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study Int J cancer 105 844 850
-
(2003)
Int J Cancer
, vol.105
, pp. 844-850
-
-
Dumeaux, V.1
Alsaker, E.2
Lund, E.3
-
31
-
-
0028147213
-
Oral contraceptives and risk of breast cancer in women aged 20-54 years
-
MA Rookus FE Van Leeuwen 1994 Oral contraceptives and risk of breast cancer in women aged 20-54 years Lancet 344 844 851
-
(1994)
Lancet
, vol.344
, pp. 844-851
-
-
Rookus, M.A.1
Van Leeuwen, F.E.2
-
33
-
-
0017708167
-
The age distribution of human cancer for carcinogenic exposures of varying intensity
-
AS Whittemore 1977 The age distribution of human cancer for carcinogenic exposures of varying intensity Am J Epidemiol 106 418 432
-
(1977)
Am J Epidemiol
, vol.106
, pp. 418-432
-
-
Whittemore, A.S.1
|